Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EVEROLIMUS Cause Multiple organ dysfunction syndrome? 197 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 197 reports of Multiple organ dysfunction syndrome have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.5% of all adverse event reports for EVEROLIMUS.

197
Reports of Multiple organ dysfunction syndrome with EVEROLIMUS
0.5%
of all EVEROLIMUS reports
177
Deaths
137
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From EVEROLIMUS?

Of the 197 reports, 177 (89.8%) resulted in death, 137 (69.5%) required hospitalization, and 68 (34.5%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 197 reports have been filed with the FAERS database.

What Other Side Effects Does EVEROLIMUS Cause?

Death (5,090) Malignant neoplasm progression (3,789) Diarrhoea (3,061) Fatigue (2,946) Stomatitis (2,692) Nausea (2,079) Dyspnoea (1,925) Drug ineffective (1,837) Pyrexia (1,664) Decreased appetite (1,633)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which EVEROLIMUS Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

EVEROLIMUS vs EVOLOCUMAB EVEROLIMUS vs EXELON EVEROLIMUS vs EXEMESTANE EVEROLIMUS vs EXENATIDE EVEROLIMUS vs EXFORGE

Related Pages

EVEROLIMUS Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome EVEROLIMUS Demographics